Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04403282 · ClinicalTrials.gov registry record · Phase 4
Topical Eflornithine for Pseudofolliculitis Barbae: Randomized Controlled Trial
A Phase 4 study, sponsored by Walter Reed National Military Medical Center.
- Terminated
- Registry status
- Phase 4
- Development phase
- 9
- Enrollment target
NCT04403282: Clinical Trial Phase 4 study, sponsored by Walter Reed National Military Medical Center.
NCT04403282 is a Phase 4 study that was terminated before completion, run by Walter Reed National Military Medical Center. The registered enrollment target is 9 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04403282, a Phase 4 study, was terminated before completion, sponsored by Walter Reed National Military Medical Center.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 9 participants
- Enrollment target
Study Summary
To study the efficacy of topical eflornithine for pseudofolliculitis barbae from a quality of life standpoint and with objective physician-measured lesion counts. Our hypothesis is that the hair growth retardation that occurs with eflornithine will perhaps reduce the frequency over time that service members need to shave which could improve the formation of PFB lesions.
Primary Outcome
number of skin lesions
Interventions
- DRUG Eflornithine Topical
- DRUG Placebo Eflornithine Topical
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2020-09-27 |
| Est. Completion | 2023-06-22 |
| Phase | Phase 4 |
Why NCT04403282 stopped before completion
NCT04403282 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 9 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 2 interventions - of which Eflornithine Topical is the first listed.
NCT04403282 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04403282 about?
NCT04403282 is a clinical study titled "Topical Eflornithine for Pseudofolliculitis Barbae: Randomized Controlled Trial". To study the efficacy of topical eflornithine for pseudofolliculitis barbae from a quality of life standpoint and with objective physician-measured lesion counts. Our hypothesis is that the hair growth retardation that occurs with eflornithine will perhaps reduce the frequency over time that service...
What is the current status of trial NCT04403282?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 9 participants. The study started on 2020-09-27. Estimated completion is 2023-06-22.
What interventions are being tested in trial NCT04403282?
The interventions under investigation include: Eflornithine Topical (DRUG), Placebo Eflornithine Topical (DRUG).
Who is sponsoring clinical trial NCT04403282?
This trial is sponsored by Walter Reed National Military Medical Center, which has 48 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04403282's enrollment target sits among peer trials
9 1968th of 2000 higher than 29 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI